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Background: The objectives of this community-based study were to examine the overall and 
changing (1990–2007) frequency and impact on 30-day and 1-year death rates from multiple 
cardiovascular comorbidities in adults from a large central New England metropolitan area 
hospitalized with acute myocardial infarction (AMI).
Methods: The study population consisted of 9581 patients hospitalized with AMI at all 
11 medical centers in the metropolitan area of Worcester, MA, during 10 annual periods between 
1990 and 2007. The comorbidities examined included atrial fibrillation, diabetes, heart failure, 
hypertension, and stroke.
Results: Thirty-five percent of participants had a single diagnosed cardiovascular comorbidity, 
25% had two, 12% had three, and 5% had four or more comorbidities. Between 1990 and 2007, 
the proportion of patients without any of these comorbidities decreased significantly, while the 
proportion of patients with multiple comorbidities increased significantly during the years under 
study. An increasing number of comorbidities was associated with higher 30-day and 1-year 
postadmission death rates in patients hospitalized with AMI.
Conclusion: Patients hospitalized with AMI carry a significant burden of comorbid 
cardiovascular disease that adversely impacts their 30-day and longer-term survival. Increased 
attention to the management of AMI patients with multiple cardiovascular comorbidities is 
warranted.
Keywords: acute myocardial infarction, comorbidities, survival, cardiovascular disease, trends, 
population-based
Introduction
Due in part to the aging of the US population, the number of individuals with   multiple 
concurrent chronic diseases has increased significantly during the past several 
decades.1–4 The presence of multiple comorbid conditions makes clinical decision-
making and patient management challenging, increases the risk for adverse outcomes, 
and is associated with higher medical care costs.5–9
Coronary artery disease disproportionately affects older individuals and is 
associated with a high burden of additional comorbidities.7,10 Although disease states 
such as diabetes, hypertension, heart failure, and atrial fibrillation share independent 
associations with increased mortality in patients with acute myocardial infarction 
(AMI),11–14 it is unclear whether these and other important comorbidities cluster 
together, or if comorbid disease burden is associated with variability in treatment or 
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reduced survival.4,15,16 Moreover, data are lacking on how 
these disease patterns, and patient-related outcomes, may 
have changed during recent years.
The objectives of the present study were to examine 
nearly 2-decade-long trends (1990–2007) in the prevalence 
of six important chronic conditions, namely atrial fibrillation, 
diabetes, heart failure, hypertension, myocardial infarction, 
and stroke, singly and in combination, in 9581 patients 
  hospitalized with AMI. These comorbid illnesses were 
selected for examination on the basis of established 
associations with the development of AMI or adverse AMI-
related prognosis and their relative frequency in this patient 
population.13,17,18 We examined the clinical correlates of mul-
tiple comorbid conditions, evaluated whether the presence 
of multiple concurrent chronic diseases influences hospital 
and posthospital admission mortality in patients hospitalized 
with AMI, and determined whether the prognosis associated 
with these chronic conditions has changed during the years 
under study. Data from the population-based Worcester Heart 
Attack Study were utilized for this investigation.19–23
Methods
The Worcester Heart Attack Study is an ongoing population-
based investigation that is examining long-term trends in the 
incidence, hospital, and postdischarge case-fatality rates of 
AMI among residents of the Worcester metropolitan area 
(2000 census estimate: 478,000) hospitalized at all 16 greater 
Worcester medical centers on an approximate biennial basis 
beginning in 1975.19–23 The periods under study were selected 
because of the availability of grant funding and for purposes 
of examining changes in our principal study outcomes over an 
approximate alternate yearly basis. Fewer hospitals (n = 11) 
have been included during recent study years due to hospital 
closures, mergers, and conversion to chronic care facilities. 
Of the current hospitals, three are considered to be tertiary 
care/university-based medical centers.
The  details  of  this  study  have  been  described 
previously.19–23 In brief, computerized printouts for patients 
admitted to all greater Worcester hospitals with primary 
and/or secondary discharge diagnosis codes consistent with 
the presence of possible AMI were obtained, and International 
Classification of Disease (ICD) codes in which AMI may 
have been diagnosed were reviewed for purposes of sample 
selection (ICD-9 codes 410–414, 786.5). Cases of possible 
AMI treated at all greater Worcester medical centers were 
independently validated according to predefined criteria for 
AMI.21–23 This study was approved by the institutional review 
board at the University of Massachusetts Medical School.
Patients who satisfied the diagnostic criteria for AMI 
and were residents of the Worcester metropolitan area were 
included in this population-based investigation. Patients 
could have been included more than once in this investigation 
if they had been rehospitalized for AMI during the different 
years under study, with subsequent reclassification of the 
order of the present AMI (eg, initial versus prior). Patients 
who developed symptoms of AMI after hospital admission 
or after an interventional procedure or surgery were excluded 
because we wanted to study AMI that occurred de novo in 
the broader community setting.
Data collection
Information about demographic characteristics, comorbidities, 
and clinical data was abstracted from the hospital medical 
records of patients with confirmed AMI by trained study 
physicians and nurses. Information was collected about 
patient age, sex, race, marital status, body mass index, 
comorbidities, AMI type (Q wave versus non-Q wave), 
hospital treatment practices, inhospital complications, and 
hospital discharge status. Discharged hospital patients were 
followed on an annual basis through review of records for 
additional hospitalizations and search of death certificates 
at state and local divisions of Vital Statistics. Some form of 
additional follow-up after being discharged from the hospital 
through either review of postdischarge medical records 
or death certificates was obtained for more than 99% of 
discharged hospital survivors from the cohorts included to 
date with follow-up completed through 2008.
The presence of prior atrial fibrillation, diabetes, heart 
failure, hypertension, and stroke was identified based on 
review of hospital medical records and physician’s progress 
notes. These comorbidities were considered to be present if 
they had been previously diagnosed in hospitalized patients. 
Patients with missing data on previously diagnosed atrial 
fibrillation (2%) were excluded from the analyses. There 
was no missing data on the other comorbidities examined. 
Multiple comorbidities were defined as the presence of one 
or more of these previously diagnosed comorbid conditions; 
further categorization into cutpoints of any two, any three, 
and at least four of these comorbidities was also carried out. 
In addition, common clusters of comorbidities among the 
six conditions examined were identified. For purposes of 
these latter analyses, a common cluster was defined as any 
combination of two or more comorbidities present in at least 
2% of the study population. The primary outcomes of interest 
were 30-day post hospital admission total death rates and 
1-year all-cause mortality.
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Data analysis
The overall prevalence of multiple comorbidities, and changes 
over time therein, were calculated and compared using the 
Chi-square test for trends. In examining whether these trends 
were affected by other patient demographic and clinical charac-
teristics, a multinomial logistic regression analysis was used to 
adjust for potential confounding factors, with patients without 
any of the comorbidities examined serving as the reference 
group. These factors were chosen based on findings from prior 
studies including age (,65, 65–74, 75–84, $85 years), sex, 
race (white versus nonwhite), marital status (single, married, 
divorced, widowed), type of AMI (Q wave versus non-Q 
wave), and clinical complications that patients may have devel-
oped during their acute hospitalization (eg, heart failure, atrial 
fibrillation, cardiogenic shock). Study years were grouped into 
five periods (1990–1991, 1993–1995, 1997–1999, 2001–2003, 
and 2005–2007) for ease of analysis.
In examining the influence of multiple comorbid 
conditions on posthospital admission, all-cause death rates, 
age-sex adjusted survival curves for 30-day and 1-year 
mortality according to number of comorbidities were created. 
In addition, multivariable-adjusted Cox regression models 
yielded estimated hazard ratios and 95% confidence intervals 
for the risk of dying at selected time points according to 
the number of cardiovascular comorbidities that had been 
previously diagnosed (a list of controlling variables is 
included in the footnotes of the tables). Proportional hazard 
assumptions were checked graphically for all variables by 
plotting a Cox model versus Kaplan-Meier curves, and the 
assumptions of these models were satisfied (data not shown). 
Interaction terms between number of comorbidities present 
and study period were included in the multivariable-adjusted 
regression models for the purpose of examining whether 
any observed associations may have changed significantly 
over time. All analyses were performed using Stata software 
(version 11.0; Stata Corporation, College Station, TX).
Results
The study sample consisted of 9581 residents of the 
Worcester metropolitan area hospitalized with independently 
validated AMI at all greater Worcester medical centers in the 
10 study years between 1990 and 2007. The average age of 
this patient population was 70 years, 57% were men, and the 
majority (93%) were Caucasian.
Prevalence of comorbidities
Overall, a total of 7379 (77%) patients had one or more of 
the comorbid conditions examined previously diagnosed 
at the time of their index hospitalization for AMI. In our 
study population, 35% of patients had a single comorbidity 
previously diagnosed, 25% had two, 12% had three, and 
5% had four or more of these clinically important comorbid 
conditions present.
The number of comorbidities previously diagnosed in 
hospitalized patients was relatively stable between 1990 
(mean 1.2, median 1) and 2007 (mean 1.6, median 1). 
However, significant changes were noted at the extremes 
of our study population distribution; the proportion of 
participants in whom no comorbid illnesses were present 
declined by nearly one-half (31% to 16%), whereas the 
number of participants with four or more comorbidities 
diagnosed previously more than doubled (3% to 7%) 
between 1990 and 2007 (Figure 1, P for trend ,0.05). 
These increasing trends remained statistically significant 
after adjusting for several potentially confounding factors 
in a multinomial logistic regression analysis (Figure 2). 
Compared with patients hospitalized during our earliest study 
years (1990–1991), patients hospitalized during the most 
recent periods under study (1997–1999, 2001–2003, and 
2005–2007) were significantly more likely to report having 
multiple comorbidities present.
Factors associated with multiple 
comorbidities
Older individuals, women, nonwhite, and widowed patients 
were more likely to have multiple comorbidities previously 
diagnosed as compared with middle-aged persons, men, white, 
and other patients hospitalized with AMI (Table 1). Patients 
with a non-Q wave AMI and those who developed serious 
clinical complications of AMI, including heart failure and atrial 
fibrillation, were more often affected by multiple comorbidities 
as compared with respective comparison groups (Table 1).
Comorbidity clustering
In order to determine the frequency and prognostic impact of 
specific comorbidity patterns (or clusters), as well as changes 
over time therein, we examined the magnitude of all pos-
sible comorbidity clusters in our study population and how 
the presence of specific comorbidity combinations related to 
short- and long-term prognosis. As shown in Figure 3, the most 
common comorbidity cluster was hypertension and diabetes, 
which occurred in one out of every eight patients hospital-
ized with AMI. Hypertension, diabetes, and heart failure was 
the next most common comorbidity combination, affecting 
approximately 5% of study patients. Both of these comorbid-
ity clusters, in addition to the combination of hypertension 
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Figure 1 Prevalence of previously diagnosed multimorbidity among patients hospitalized with acute myocardial infarction according to study period.
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Figure 2 Changing trends of previously diagnosed cardiovascular comorbidities by study year.
Notes: Multinomial logistic regression model adjusted for age, sex, race, marital status, type of myocardial infarction (Q wave versus non-Q wave) and acute hospital 
complications (atrial fibrillation, heart failure, cardiogenic shock). Relative risk ratios (95% CI) calculated from multinominal logistic regression model and referent group 
includes patients without any comorbidity. 
Abbreviation: CI, confidence interval.
and atrial fibrillation, increased in prevalence over the study 
period (Figure 3, P for trend , 0.05). These increasing trends 
remained statistically significant after adjusting for a number of 
potentially confounding demographic and clinical factors in a 
multinominal logistic regression model (data not shown).
Mortality associated with multiple 
comorbidities and clusters  
of comorbidities
In examining the relationship between number of comorbidi-
ties and all-cause mortality, having multiple comorbidities 
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previously diagnosed prior to hospitalization for AMI was 
significantly associated with poorer short- and long-term 
  survival (Table 2, Figure 4). After adjustment for several 
potentially confounding demographic (eg, age, sex) and 
  clinical factors (eg, hospital clinical complications) of 
  prognostic importance, patients with two or more comorbidi-
ties were significantly more likely to have died within 30 days 
or at 1 year after hospital admission (Table 2). The risk of 
dying within 30 days and at 1 year after admission for AMI 
was directly related to the number of comorbidities present. 
The prognosis associated with having multiple comorbidi-
ties among patients hospitalized with AMI did not change 
significantly over time (P = 0.57 for interaction).
Patients with AMI and several of the most common comor-
bidity clusters were at higher risk for dying within 30 days and 
at 1 year after hospital admission, even after adjustment for 
several potentially confounding factors (Table 3). In particular, 
patients with the following combinations: hypertension + heart 
failure, hypertension + stroke, hypertension + diabetes + heart 
failure, or hypertension + diabetes + stroke, had greater odds 
of dying within 30 days or by 1 year after hospitalization for 
AMI than patients without these comorbid conditions.
Discussion
In this community-wide investigation of central Massachusetts 
residents hospitalized with an independently validated AMI 
Table 1 Patient characteristics according to number of previously diagnosed cardiovascular comorbidities in patients hospitalized with 
acute myocardial infarction
Characteristic,  
n (%)
No comorbidity  
(n = 2202)
1  
(n = 3377)
2  
(n = 2381)
3  
(n = 1186)
$4  
(n = 435)
P value
Age group, years
 , 65 1202 (38.6) 1161 (37.3) 541 (17.4) 161 (5.2) 47 (1.5) ,0.001
  65–74 459 (20.2) 792 (34.9) 616 (27.1) 299 (13.2) 106 (4.7)
  75–84 377 (14.0) 921 (34.1) 757 (28.1) 454 (16.8) 190 (7.0)
 $ 85 159 (11.4) 461 (33.0) 438 (31.3) 255 (18.2) 86 (6.2)
Sex
  Men 1551 (28.4) 1910 (35.0) 1221 (22.4) 558 (10.2) 217 (4.0) ,0.001
  Women 651 (16.0) 1467 (35.6) 1160 (28.1) 628 (15.2) 218 (5.3)
Race
  White 2007 (23.1) 3101 (35.6) 2155 (24.7) 1056 (12.1) 402 (4.6) 0.006
  Nonwhite 120 (13.4) 202 (32.6) 171 (27.6) 100 (16.2) 26 (4.2)
Marital status
  Single 282 (23.4) 392 (35.3) 279 (25.1) 136 (12.2) 23 (2.1) ,0.001
  Married 1402 (26.5) 1881 (35.6) 1243 (23.5) 541 (10.2) 224 (4.2)
  Divorced 166 (25.2) 250 (38.0) 149 (22.6) 66 (10.0) 27 (4.1)
  Widowed 322 (13.7) 796 (33.9) 660 (28.1) 416 (17.7) 151 (6.4)
Type of AMI
  Q wave 983 (33.6) 1133 (38.7) 577 (19.7) 196 (6.7) 38 (1.3) ,0.001
  Non-Q wave 1210 (18.4) 2226 (3.8) 1781 (27.0) 984 (14.9) 390 (5.9)
Hospital complications
Atrial fibrillation
  Yes 250 (14.5) 522 (30.3) 492 (28.6) 311 (18.1) 148 (8.6) ,0.001
  No 1952 (24.8) 2855 (36.3) 1889 (24.0) 875 (11.1) 287 (3.7)
Heart failure
  Yes 486 (13.2) 1032 (28.1) 1104 (30.1) 756 (20.6) 295 (8.0) ,0.001
  No 1716 (29.1) 2345 (39.7) 1277 (21.6) 430 (7.3) 140 (2.4)
Cardiogenic shock
  Yes 121 (20.2) 213 (35.6) 155 (25.9) 87 (14.6) 22 (3.7) 0.208
  No 2081 (23.2) 3164 (35.2) 2226 (24.0) 1099 (12.2) 413 (4.6)
Study period
  1990–1991 426 (30.8) 494 (35.7) 314 (22.7) 107 (7.7) 43 (3.1) ,0.001
  1993–1995 530 (27.9) 761 (36.9) 444 (23.3) 179 (9.4) 48 (2.5)
  1997–1999 485 (23.3) 761 (36.5) 495 (23.8) 247 (11.9) 96 (4.6)
  2001–2003 466 (19.5) 797 (33.3) 646 (27.0) 364 (15.2) 123 (5.1)
  2005–2007 295 (26.3) 624 (34.4) 482 (26.6) 289 (15.9) 125 (6.9)
Note: Comorbidities examined included atrial fibrillation, diabetes, heart failure, hypertension, and stroke. 
Abbreviation: AMI, acute myocardial infarction.
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at all metropolitan Worcester medical centers between 1990 
and 2007, the prevalence of previously diagnosed atrial 
fibrillation, heart failure, diabetes mellitus, and hypertension 
increased over time in hospitalized patients, as did the odds 
of being diagnosed with multiple comorbidities. Although 
the median number of comorbidities that were previously 
diagnosed in this patient population did not increase between 
1990 and 2007, a dramatic increase in the percentage of 
hospitalized patients having four or more comorbid illnesses 
was observed, as was a concomitant decline in the propor-
tion of patients without any of the comorbidities examined. 
The prevalence of several comorbidity combinations, 
most notably hypertension and diabetes, increased among 
AMI patients during the years under study. An increasing 
number of comorbid diseases was inversely associated with 
survival at 30 days and 1 year after admission to all central 
Massachusetts medical centers. In addition, despite increases 
in the proportion of patients with the highest burden of 
comorbidity, the adverse prognosis associated with having 
multiple comorbidities did not change significantly over the 
nearly 2-decade-long period under study.
Consistent with the published literature, we observed a 
high prevalence of the important cardiovascular comorbidities 
of atrial fibrillation, heart failure, prior MI, diabetes mellitus, 
Table 2 Crude and multivariable-adjusted* 30-day and 1-year mortality according to number of previously diagnosed cardiovascular 
comorbidities in patients hospitalized with acute myocardial infarction
Comorbidities  
(n)
30-day mortality 1-year mortality
Dead (n, %) Hazard ratio (95% CI) Dead (n, %) Hazard ratio (95% CI)
0 198 (9.01) 1.00 330 (15.02) 1.00
1 439 (13.03) 1.19 (0.93–1.35) 760 (22.56) 1.16 (1.01–1.34)
2 422 (17.76) 1.49 (1.23–1.80) 816 (34.34) 1.62 (1.41–1.87)
3 252 (21.32) 1.64 (1.32–2.03) 532 (45.01) 1.94 (1.66–2.26)
$4 97 (22.30) 1.68 (1.28–2.21) 233 (53.56) 2.31 (1.91–2.78)
Notes: Comorbidities examined included atrial fibrillation, diabetes, heart failure, hypertension, and stroke. *Cox proportional hazards regression model adjusted for age, 
sex, race, marital status, study year, MI type (Q-wave versus non-Q wave) and acute hospital complications (atrial fibrillation, heart failure, cardiogenic shock). 
Abbreviations: CI, confidence interval; MI, myocardial infarction.
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Figure 3 Proportion of patients with selected combinations of previously diagnosed cardiovascular comorbidities among patients hospitalized with acute myocardial 
infarction according to study period.
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hypertension, and stroke in our patient population.13,24–26 The 
proportion of AMI patients affected by these comorbidities 
increased during the period under study, with the exception 
of prior MI and stroke. Our results confirm the findings of 
other contemporary investigations that have studied patients 
hospitalized with AMI, such as those from National Registry 
of Myocardial Infarction-2, which have also shown that the 
burden of atrial fibrillation, heart failure, diabetes mellitus, 
hypertension, and stroke have increased in this large multi-
regional population.10 Given the strong relationship between 
age, sex, and adiposity with the cardiovascular conditions 
under study, the observed trends are likely related to the 
increasing number of elderly, women, and obese patients 
hospitalized with AMI in our study population.17,22,27
A major focus of the present investigation was to examine 
the magnitude of cardiometabolic comorbidities in patients 
hospitalized with AMI. The vast majority (.80%) of patients 
in our study sample were affected by at least one of the 
comorbidities under study, and more than half were affected 
by two or more comorbid diseases; indeed, approximately 
one in every eight patients had four or more of the cardiovas-
cular comorbidities examined. Although limited data on this 
topic exist, these observations validate our clinical impres-
sion that cardiovascular “multimorbidity” is the rule rather 
than the exception in patients hospitalized with AMI.4,15,16 
Notably, rates of multimorbidity in our study were similar 
to, but slightly higher than, rates observed in similarly aged 
individuals included in prior investigations.7,8
There are several possible explanations for the high 
rates of multimorbidity observed in our hospitalized patient 
population. First, in light of the strong pathophysiological 
associations between diseases such as hypertension and heart 
failure, “causal comorbidity” has likely contributed to clus-
tering of these diseases in our middle-aged and elderly patient 
population. “Complicating comorbidity,” or the strong causal 
relationship between one disease and another, for example, 
between hypertension and stroke or obesity and diabetes, 
may also explain the frequent clustering of comorbidities in 
our study sample.28
The prevalence of patients without important cardio-
vascular comorbidities has decreased significantly, while 
the prevalence of patients with multiple comorbidities has 
increased significantly during the years under study in this 
population-based investigation. Reasons for the increasing 
rates of multimorbidity in our sample likely include enhanced 
risk factor and disease screening as well as improved patient 
and provider awareness of the importance of these chronic 
conditions between 1990 and 2007.17 However, the strong 
association between age, obesity, and several of the examined 
comorbidities, both singly and in combination, suggests that 
the increasing age and adiposity of patients hospitalized with 
AMI noted over time may also have contributed to observed 
trends. This hypothesis is supported by our observation that 
Table 3 Crude and multivariable-adjusted 30-day and 1-year mortality according to combination of previously diagnosed cardiovascular 
comorbidities
Comorbidity combination n 30-day mortality 1-year mortality
Dead (n, %) Hazard ratio (95% CI) Dead (n, %) Hazard ratio (95% CI)
No comorbidity 202 19 (9.0) 1.00 330 (15.0) 1.00
Hypertension/diabetes 1173 136 (11.6) 1.09 (0.85–1.39) 270 (23.0) 1.27 (1.06–1.50)
Hypertension/heart failure 467 123 (26.5) 1.82 (1.41–2.34) 239 (51.4) 1.90 (1.58–2.29)
Hypertension/atrial fibrillation 233 35 (15.2) 1.16 (0.79–1.71) 73 (31.6) 1.21 (0.92–1.59)
Hypertension/stroke 224 47 (21.0) 1.73 (1.21–2.47) 84 (37.5) 1.76 (1.36–2.28)
Hypertension, diabetes, and heart failure 507 92 (18.2) 1.40 (1.06–1.85) 214 (42.3) 1.79 (1.48–2.16)
Hypertension, diabetes, and stroke 202 45 (22.2) 1.85 (1.30–2.62) 90 (44.6) 2.17 (1.69–2.79)
Other combinations 4573 732 (16.1) 1.31 (1.10–1.57) 1371 (30.1) 1.43 (1.35–1.63)
Notes: Cox proportional hazard regression model adjusted for age, sex, race, marital status, study year, type of acute myocardial infarction (Q wave versus non-Q wave) 
and acute hospital complications (atrial fibrillation, heart failure, cardiogenic shock). Comparisons are between patients with selected comorbidity clusters and patients 
without any comorbidity.
1
0
0
8
0
2
0
0
6
0
4
0
%
 
s
u
r
v
i
v
i
n
g
0369 12
Months since admission
Comorbidity = 0C omorbidity = Any 1
Comorbidity = Any 2C omorbidity = Any 3
Comorbidity = 4 or more
Figure 4 1-year age- and sex-adjusted survival rates among patients with acute 
myocardial infarction according to number of previously diagnosed cardiovascular 
comorbidities.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
121
Comorbidities and AMIClinical Epidemiology 2012:4
the proportion of patients affected by specific comorbidity 
clusters that are strongly related to advancing age and 
obesity, such as hypertension and diabetes, increased most 
significantly over the study period. Similarly, because women 
and nonwhite patients with AMI were more likely to have 
multiple comorbidities, the increasing proportion of these 
patients in our community sample may have also contributed 
to increasing rates of multimorbidity noted during the years 
under study.
As has been reported previously, patients who reported 
having any of the cardiovascular comorbidities under study 
(with the exception of hypertension) were more likely to die 
during the first year after admission for AMI. We observed 
that having multiple comorbidities present was significantly 
associated with poorer survival at 30 days and 1 year after 
hospital admission for AMI and that the overall risk of dying 
increased linearly with the number of comorbidities present. 
These data suggest that the concomitant occurrence of 
multiple comorbid diseases exerts a more significant adverse 
effect on the short-term and long-term health of patients 
with an AMI than when they occur singly.7,16 Our findings 
are supported by several prior investigations, including one 
involving more than 100,000 Medicare beneficiaries, which 
showed that the odds of clinical complications increased 
exponentially with increasing number of comorbidities (one 
comorbidity = four complications per 1000 beneficiaries; four 
comorbidities = 34 complications per 1000 beneficiaries).8
Our observation that multimorbidity is associated with 
poor short-term and better long-term survival is likely 
related to the fact that health care providers have little help in 
adjusting care for patients with multiple conditions, given that 
clinical trials and, in turn, practice guidelines, focus almost 
exclusively on patients with a single disease entity. Rates 
of complications from AMI treatment, such as bleeding,29 
may be higher in patients with multiple comorbidities than 
in patients without any comorbid illness, due to factors such 
as drug–drug interactions or reduced drug clearance. Our 
results suggest that further population-based data on the use 
and impact of contemporary AMI treatments in patients with 
multiple comorbidities are needed.
Study strengths and limitations
The strengths of the present study include its community-
based design, its large sample of patients hospitalized 
with AMI, and its almost 2-decade-long perspective into 
changing trends in several clinically relevant endpoints. Our 
study limitations must also be recognized. First, although 
trends in the death rates of patients with AMI may have 
been influenced by cardiac treatments, our study did not 
examine the role and impact of hospital treatment practices, 
given the observational nature of this investigation, and our 
nonrandomized study design did not allow for adjustment 
for differences in these practices. Given that the majority 
of our study participants were white, our findings may lack 
generalizability to other ethnic or racial groups. Finally, 
physician thresholds for diagnosing several of the comorbid 
conditions under study may have changed over time, though 
it is unknown whether such a trend has occurred in our study 
population.
Conclusion
In this study of almost 10,000 patients hospitalized with AMI 
over a recent 2-decade period, we observed that the odds of 
having multiple cardiovascular comorbidities previously 
diagnosed in these high-risk patients increased significantly 
over time. Presence of multimorbidity was associated with 
reduced short- and long-term survival and the poor prognosis 
associated with multimorbidity persisted over the period 
under study. Our findings highlight the need for additional 
contemporary data to help guide the monitoring and treat-
ment of patients with cardiovascular disease and multiple 
concurrent medical illnesses, as well as the importance of 
skilled and coordinated cardiovascular care for these high-
risk patients.
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